Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arreaza, L. Articles by Vázquez, J. A. Search for Related Content PubMed PubMed Citation Articles by Arreaza, L. Articles by Vázquez, J. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2004, p. 358-359, Vol. 48, No. 1
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.1.358-359.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Sequencing of Neisseria meningitidis penA Gene: the Key to Success in Defining Penicillin G Breakpoints

Luisa Arreaza, Celia Salcedo, Belén Alcalá, María José Uría, Raquel Abad, Rocío Enríquez, and Julio A. Vázquez^*

Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, Madrid, Spain

Received 17 June 2003/ Returned for modification 18 August 2003/ Accepted 26 September 2003

Top Abstract Introduction Nucleotide sequence accession... References

 
Testing of susceptibility to penicillin G by E-test and sequencing of an internal fragment of the penA gene were done for 43 meningococcal strains. Those strains for which the MIC was 0.094 µg/ml showed mosaic alleles, so 0.094 µg/ml is suggested as the penicillin G intermediate breakpoint when E-test is used.

Top Abstract Introduction Nucleotide sequence accession... References

 
Methods recommended for the susceptibility testing of Neisseria meningitidis include broth microdilution and agar dilution (AD) (4). However, over the last few decades E-test has been frequently used for meningococcal susceptibility analysis, because it is simple to use and is applicable for single-isolate susceptibility testing (3). E-test uses a continuous antibiotic concentration gradient, and as a result, the MICs obtained might be more precise than conventional MICs, based on discontinuous twofold serial dilutions.

Penicillin-resistant meningococcal strains are extremely rare and are related with ß-lactamase production. However, those defined as intermediate (Penⁱ) have been widely described in different countries (7), although their clinical significance is still not clear. The Penⁱ strains show altered forms of the penicillin-binding protein 2. This fact is due to genetic events at the penA gene, which encodes that protein. So, while the penA gene of penicillin-susceptible strains (Pen^s strains) appears uniform in sequence, those from Penⁱ strains are quite diverse, showing mosaic structures (6).

So far, 0.12 µg/ml has been used as a cutoff point for Penⁱ definition for N. meningitidis when the susceptibility analysis is done by AD or broth macrodilution (2, 5), so strains for which the penicillin G MIC is 0.06 µg/ml are defined as susceptible and those for which MICs range between 0.12 and 1.0 µg/ml are considered intermediate. Strains for which MICs are between 0.06 and 0.12 µg/ml when E-test is used can be found, but so far they cannot be properly categorized. Although a MIC of 0.094 as determined by E-test is rounded up to fit the classical dilution scheme, it is not known if these isolates are properly assigned to the intermediate resistance category or not.

Because the molecular basis of Penⁱ in N. meningitidis is based on detection of mosaic structures at the penA gene, the aim of this study was to establish the Penⁱ breakpoint, when the susceptibility analysis is done by E-test, by penA gene sequencing.

Forty-three strains (13 serogroup B, 28 serogroup C, 1 serogroup 29E, and 1 serogroup W135 strain) isolated from cases of invasive meningococcal disease in Spain were included.

Susceptibility to penicillin G was determined by E-test in Mueller-Hinton agar supplemented with 5% whole defibrinated sheep blood. E-test was carried out according to the manufacturer's instructions by using CO₂ incubation. The MICs were determined twice for each strain by two people independently reading the values on the E-test strips.

A 1.4-kb DNA fragment of the penA gene, encoding the transpeptidase domain, was amplified from the chromosomal DNA of N. meningitidis by PCR, purified and sequenced, as previously described (1).

All the strains for which the MIC was 0.047 µg/ml as determined by E-test possessed penA alleles related to Pen^s strains. Mosaic penA alleles were identified in all the strains for which the MIC was 0.094 µg/ml. Among those strains for which the MIC was 0.064 µg/ml (n = 9), two groups were defined according to the penA gene sequence: five isolates showed penA alleles related with Pen^s strains and four isolates possessed mosaic penA alleles. The results are summarized in Table 1, where the MICs determined by AD, which is routinely done in our laboratory, are also included.

View this table: [in this window] [in a new window]

TABLE 1. Relationship between penicillin G MIC determined by E-test and penA gene sequence

A similar correlation can be found between AD and penA polymorphism (Table 1). All the strains for which the MIC was <0.06 µg/ml showed penA alleles of Pen^s meningococci, while mosaic alleles were identified in those for which the MIC was >0.06. Once again there was a less clear correlation with the isolates for which the MIC was 0.06 µg/ml, with three of eight strains showing mosaic penA alleles. On the other hand, it is important that 23 strains for which the MIC was 0.12 µg/ml as determined by AD were used in this study (Table 1). For 13 of them the MIC was 0.094 µg/ml by E-test, so the frequency of meningococcal strains for which the MIC is that value, as determined by E-test, might be very high.

Because in our laboratory the meningococcal isolates are routinely tested against other ß-lactam antibiotics (ampicillin, cefotaxime, and ceftriaxone), for those strains for which the penicillin G MIC was 0.064 µg/ml, the MICs of other ß-lactams were studied. The most relevant finding was that, for all the strains showing mosaic structures at the penA gene, ampicillin MICs determined by E-test were 0.125 µg/ml. However, for those strains possessing penA alleles related to susceptible strains, ampicillin MICs were lower (0.094 µg/ml) (Table 2).

View this table: [in this window] [in a new window]

TABLE 2. Relationship between penicillin G and ampicillin MICs determined by E-test and mosaic penA alleles

According to these results, 0.094 µg/ml should be used as the Penⁱ breakpoint when E-test is used as the susceptibility testing method. The heterogeneous situation found among strains for which the MIC was 0.064 µg/ml as determined by E-test determines that isolates for which the MIC is at this level should be defined as susceptible in order to avoid an overestimation of the Penⁱ meningococcal population. The evaluation of different inocula and/or media in the E-test susceptibility testing method could be important for clarifying the confusing situation found for those isolates for which the MIC was 0.064 µg/ml. However, the level of susceptibility to ampicillin might be used in order to decide properly if those isolates for which the penicillin G MIC determined by E-test was 0.064 µg/ml should be included in the Pen^s or Penⁱ group.

Although we have found a good correlation between determination of the MIC with E-test and sequence variation in the penA gene, the possibility of other mechanisms that cause resistance should not be discarded.

Top Abstract Introduction Nucleotide sequence accession... References

 
The nucleotide sequences reported in this study were deposited in the GenBank database under accession numbers AF519582, AF519584, AF519585, AF519586, AF519588, AF519590, AF519579, AF519581, AF519591, AF519587, AF519577, AF519575, AF519576, AF519589, AY292990 to AY293001, AY294547 to AY294556, AF519596, AF519603, AF519607, AF519609, AF519612, AF519616, and AF519617.

 
This study was supported by grants 01/18 and QLK2-CT-2001-01436 from Instituto de Salud Carlos III and the European Commission, respectively. C. Salcedo and R. Enríquez worked with a predoctoral fellowship from Wyeth España. M. J. Uría and R. Abad were supported by grants from FIS and ISCIII, respectively. A postdoctoral fellowship from Instituto de Salud Carlos III supported B. Alcalá.

 
* Corresponding author. Mailing address: Reference Laboratory for Meningococci, National Center of Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain. Phone: 34915097901. Fax: 34915097966. E-mail: jvazquez{at}isciii.es.

Top Abstract Introduction Nucleotide sequence accession... References

 

1
1. Arreaza, L., and J. A. Vázquez. 2001. Molecular approach for the study of penicillin resistance in Neisseria meningitidis. Methods Mol. Med. 67:107-119.
2
2. Arreaza, L., L. de la Fuente, and J. A. Vázquez. 2000. Antibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers. Antimicrob. Agents Chemother. 44:1705-1707.[Abstract/Free Full Text]
3
3. Block, C. 2001. Antibiotic susceptibility testing. Methods Mol. Med. 67:89-106.
4
4. National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing. Eleventh Informational Supplement. NCCLS document M100-S11. National Committee for Clinical Laboratory Standards, Wayne, Pa.
5
5. Rosenstein, N. E., S. A. Stocker, T. Popovic, F. C. Tenover, B. A. Perkins, and the Active Bacterial Core Surveillance (ABCs) Team. 2000. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. Clin. Infect. Dis. 30:212-213.[CrossRef][Medline]
6
6. Spratt, B. G., L. D. Bowler, Q.-Y. Zhang, J. Zhou, and J. M. Smith. 1992. Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J. Mol. Evol. 34:115-125.[Medline]
7
7. Vázquez, J. A. 2001. The resistance of Neisseria meningitidis to the antimicrobial agents: an issue still in evolution. Rev. Med. Microbiol. 12:39-45.

---

Antimicrobial Agents and Chemotherapy, January 2004, p. 358-359, Vol. 48, No. 1
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.1.358-359.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• du Plessis, M., von Gottberg, A., Cohen, C., de Gouveia, L., Klugman, K. P., for the Group for Enteric Respiratory and Meningea, (2008). Neisseria meningitidis Intermediately Resistant to Penicillin and Causing Invasive Disease in South Africa in 2001 to 2005. J. Clin. Microbiol. 46: 3208-3214 [Abstract] [Full Text]  
• Thulin, S., Olcen, P., Fredlund, H., Unemo, M. (2008). Combined Real-Time PCR and Pyrosequencing Strategy for Objective, Sensitive, Specific, and High-Throughput Identification of Reduced Susceptibility to Penicillins in Neisseria meningitidis. Antimicrob. Agents Chemother. 52: 753-756 [Abstract] [Full Text]  
• Taha, M.-K., Vazquez, J. A., Hong, E., Bennett, D. E., Bertrand, S., Bukovski, S., Cafferkey, M. T., Carion, F., Christensen, J. J., Diggle, M., Edwards, G., Enriquez, R., Fazio, C., Frosch, M., Heuberger, S., Hoffmann, S., Jolley, K. A., Kadlubowski, M., Kechrid, A., Kesanopoulos, K., Kriz, P., Lambertsen, L., Levenet, I., Musilek, M., Paragi, M., Saguer, A., Skoczynska, A., Stefanelli, P., Thulin, S., Tzanakaki, G., Unemo, M., Vogel, U., Zarantonelli, M. L. (2007). Target Gene Sequencing To Characterize the Penicillin G Susceptibility of Neisseria meningitidis. Antimicrob. Agents Chemother. 51: 2784-2792 [Abstract] [Full Text]  
• Thulin, S., Olcen, P., Fredlund, H., Unemo, M. (2006). Total Variation in the penA Gene of Neisseria meningitidis: Correlation between Susceptibility to {beta}-Lactam Antibiotics and penA Gene Heterogeneity.. Antimicrob. Agents Chemother. 50: 3317-3324 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arreaza, L. Articles by Vázquez, J. A. Search for Related Content PubMed PubMed Citation Articles by Arreaza, L. Articles by Vázquez, J. A.